Internal thoracic artery graft failure and recurrence of symptoms following single-vessel coronary artery bypass graft surgery.


Journal

Journal of cardiothoracic surgery
ISSN: 1749-8090
Titre abrégé: J Cardiothorac Surg
Pays: England
ID NLM: 101265113

Informations de publication

Date de publication:
07 Oct 2023
Historique:
received: 25 02 2022
accepted: 30 09 2023
medline: 9 10 2023
pubmed: 8 10 2023
entrez: 7 10 2023
Statut: epublish

Résumé

Coronary events and disease recurrence following coronary artery bypass (CABG) surgery could derive from either failure in the internal thoracic artery (ITA) graft, failure in other conduits or progressive disease in the coronaries. We aim to estimate the contribution of ITA graft failure to the recurrence of symptoms after CABG surgery. Within the Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies registry, we identified patients who had coronary artery bypass grafting from 1997 to 2020 with a single-vessel ITA graft bypass. Deaths, postoperative incidence of coronary angiography and the presence of a failed graft at the time of the angiography were recorded. The study population consisted of 1939 patients with a mean follow-up time (SD) of 17.2 (5.6) years. The cumulative incidence (95% CI) at 20 years for a first clinically-driven postoperative angiography was 38.6% (36.2-41.1). A failed ITA graft was reported in 16.4% of the angiographies. A substantial part of recurrent symptoms of coronary artery disease do not seem to be related to ITA failure. Disease progression in the native coronary vessels may instead be the main driver of symptom recurrence.

Identifiants

pubmed: 37805490
doi: 10.1186/s13019-023-02384-1
pii: 10.1186/s13019-023-02384-1
pmc: PMC10560409
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

273

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

Loop FD, Lytle BW, Cosgrove DM, Stewart RW, Goormastic M, Williams GW, et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med. 1986;314:1–6.
doi: 10.1056/NEJM198601023140101 pubmed: 3484393
Goldman S, Zadina K, Moritz T, Ovitt T, Sethi G, Copeland JG, et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol. 2004;44:2149–56.
doi: 10.1016/j.jacc.2004.08.064 pubmed: 15582312
Alexander JH, Hafley G, Harrington RA, Peterson ED, Ferguson TB Jr, Lorenz TJ, et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA. 2005;294:2446–54.
doi: 10.1001/jama.294.19.2446 pubmed: 16287955
van der Meer J, Hillege HL, van Gilst WH, Brutel de laRiviere A, Dunselman PH, Fidler V, et al. A comparison of internal mammary artery and saphenous vein grafts after coronary artery bypass surgery. No difference in 1-year occlusion rates and clinical outcome. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Circulation. 1994;90:2367–74.
doi: 10.1161/01.CIR.90.5.2367 pubmed: 7955195
Shavadia J, Norris CM, Graham MM, Verma S, Ali I, Bainey KR. Symptomatic graft failure and impact on clinical outcome after coronary artery bypass grafting surgery: results from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease registry. Am Heart J. 2015;169:833–40.
doi: 10.1016/j.ahj.2015.02.022 pubmed: 26027621
Yamasaki M, Deb S, Tsubota H, Moussa F, Kiss A, Cohen EA, et al. Comparison of radial artery and saphenous vein graft stenosis more than 5 years after coronary artery bypass grafting. Ann Thorac Surg. 2016;102:712–9.
doi: 10.1016/j.athoracsur.2016.02.107 pubmed: 27154160
Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation. 1998;97:916–31.
doi: 10.1161/01.CIR.97.9.916 pubmed: 9521341
Lopes RD, Mehta RH, Hafley GE, Williams JB, Mack MJ, Peterson ED, et al. Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery. Circulation. 2012;125:749–56.
doi: 10.1161/CIRCULATIONAHA.111.040311 pubmed: 22238227 pmcid: 3699199
Hess CN, Lopes RD, Gibson CM, Hager R, Wojdyla DM, Englum BR, et al. Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV. Circulation. 2014;130:1445–51.
doi: 10.1161/CIRCULATIONAHA.113.008193 pubmed: 25261549 pmcid: 4206593
Harskamp RE, Alexander JH, Ferguson TB Jr, Hager R, Mack MJ, Englum B, et al. Frequency and predictors of internal mammary artery graft failure and subsequent clinical outcomes: insights from the project of ex-vivo vein graft engineering via transfection (PREVENT) IV trial. Circulation. 2016;133:131–8.
doi: 10.1161/CIRCULATIONAHA.115.015549 pubmed: 26647082
Cao C, Manganas C, Horton M, Bannon P, Munkholm-Larsen S, Ang SC, et al. Angiographic outcomes of radial artery versus saphenous vein in coronary artery bypass graft surgery: a meta-analysis of randomized controlled trials. J Thorac Cardiovasc Surg. 2013;146:255–61.
doi: 10.1016/j.jtcvs.2012.07.014 pubmed: 22871565
Taggart DP, Altman DG, Gray AM, Lees B, Gerry S, Benedetto U, et al. Randomized trial of bilateral versus single internal-thoracic-artery grafts. N Engl J Med. 2016;375:2540–9.
doi: 10.1056/NEJMoa1610021 pubmed: 27959712
Gaudino M, Alexander JH, Bakaeen FG, Ballman K, Barili F, Calafiore AM, et al. Randomized comparison of the clinical outcome of single versus multiple arterial grafts: the ROMA trial-rationale and study protocol. Eur J Cardiothorac Surg. 2017;52:1031–40.
doi: 10.1093/ejcts/ezx358 pubmed: 29059371
Gaudino M, Benedetto U, Fremes S, Ballman K, Biondi-Zoccai G, Sedrakyan A, et al. Association of radial artery graft vs saphenous vein graft with long-term cardiovascular outcomes among patients undergoing coronary artery bypass grafting: a systematic review and meta-analysis. JAMA. 2020;324:179–87.
doi: 10.1001/jama.2020.8228 pubmed: 32662861 pmcid: 7361649
Taggart DP, Benedetto U, Gerry S, Altman DG, Gray AM, Lees B, et al. Bilateral versus single internal-thoracic-artery grafts at 10 years. N Engl J Med. 2019;380:437–46.
doi: 10.1056/NEJMoa1808783 pubmed: 30699314
Jernberg T, Attebring MF, Hambraeus K, Ivert T, James S, Jeppsson A, et al. The Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART). Heart. 2010;96:1617–21.
doi: 10.1136/hrt.2010.198804 pubmed: 20801780
Janiec M, Friberg O, Thelin S. Long-term clinical outcomes after coronary artery bypass grafting with pedicled saphenous vein grafts. J Cardiothorac Surg. 2018;13:122.
doi: 10.1186/s13019-018-0800-z pubmed: 30477543 pmcid: 6258143

Auteurs

Mikael Janiec (M)

Department of Cardiothoracic Surgery and Anesthesiology, Uppsala University Hospital, Uppsala, Sweden. mikael.janiec@surgsci.uu.se.
Department of Surgical Sciences, Uppsala University, Uppsala, Sweden. mikael.janiec@surgsci.uu.se.

Axel Dimberg (A)

Department of Cardiothoracic Surgery, Karolinska University Hospital, Stockholm, Sweden.

Rickard P F Lindblom (RPF)

Department of Cardiothoracic Surgery and Anesthesiology, Uppsala University Hospital, Uppsala, Sweden.
Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH